The U.S. Food and Drug Administration has approved AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) for both the ...

Merck is racing to defend its leadership in the market for cancer drugs ahead of Keytruda’s looming patent cliff. A clinical ...

The news adds two concrete pillars to the Keytruda “patent wall”: (1) Phase 3 OptiTROP-Lung05 shows Keytruda + sac-TMT beats ...

Treatment with the TROP2 ADC sac-TMT led to a 70% objective response rate and progression-free survival was “significantly ...

Merck (MRK) stock gains as a cancer drug the company develops with Kelun-Biotech bests its Keytruda blockbuster in a ...

By Siddhi Mahatole May 21 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical said on Thursday its experimental treatment ...

Dr Hilary Jones has praised a new NHS injection that not only takes 60 seconds to administer but is also set to help tens of ...

Vast numbers of NHS patients and staff throughout England are expected to reap the benefits of the injection, reports the Mirror. Dr Hilary explained: "It is replacing an intraven ...

The advanced lung cancer inflammation index (ALI)—a composite marker integrating body mass index, albumin levels, and the neutrophil-to-lymphocyte ratio—has emerged as a potential prognostic tool for ...

Tens of thousands of patients could benefit from a one-minute jab being rolled out on the NHS for more than a dozen cancers.

Tens of thousands of NHS patients could soon spend just minutes receiving a life-saving cancer treatment thanks to a new injection being rolled out across England. The NHS has begun offering a new ...

Until now, patients have had to spend hours on a drip to get the drug pembrolizumab (Keytruda) to treat their cancer.